Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of botulinum toxin type A for crow's feet lines; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crow Feet Lines
• Lateral Canthus Rhytides

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Lateral Canthus Rhytides, Crow's Feet Lines | Phase 3 | Status: COMPLETED | Results posted: 2013-12-03